-
admin
Posts
Jianzhi Education Technology Group Company Limited Announces Closing of $5 Million Registered Direct Offering
BEIJING, June 4, 2026 /PRNewswire/ — Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) (the “Company” or “Jianzhi“) today announced the closing of its previously...
YY Group (NASDAQ: YYGH) Advances AI Training Data Strategy with Launch of Training Lab and Pilot Robotics Deployments in Singapore
Singapore Humanoid Robot Training Lab Powered by NVIDIA Accelerated Computing Technology Establishes a “Human-Robot Co-Working” framework, positioning the Company to offer AI-enhanced labor solutions across...
NYSE Content Update: Intercontinental Exchange Joins Anthropic’s Project Glasswing
NYSE issues a midday advisory direct from the trading floor. NEW YORK, June 4, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a...
Bread Financial to Participate in the Morgan Stanley US Financials Conference
COLUMBUS, Ohio, June 03, 2026 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending,...
MINILUXE ANNOUNCES CLOSING OF OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF OVER US$5 MILLION (~CDN$7 MILLION)
Building on the momentum of its unit economics, the Company successfully closes another private placement at a premium to market and with oversubscription NOT FOR...
iHerb’s 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia
IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) — iHerb, a globally renowned health and wellness e-commerce platform, which has been established for 29 years, recently...
Xcube.bio Strengthens Board with Appointment of Three Distinguished Non-Executive Directors
ZUG, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) — Xcubebio AG, a market entry acceleration engine for innovative biopharma and transformative therapeutics, today announced the appointments...
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
NAARDEN, The Netherlands and MIAMI, June 03, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical...
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmacokinetics of pilavapadin across renal function groups THE WOODLANDS, Texas, June 03, 2026...
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
First-in-human study of SOT106 to be initiated in second half of 2026, advancing a differentiated LRRC15 ADC toward early clinical signal PRAGUE, Czech Republic, BASEL,...
